+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Renal Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 170 Pages
  • Global
From
Anal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Vestibular Schwannoma - Pipeline Insight, 2024 - Product Thumbnail Image

Vestibular Schwannoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Clear Cell Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Clear Cell Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Desmoid Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Paranasal sinus cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Paranasal sinus cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Meningioma - Pipeline Insight, 2024 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Microsatellite Stable Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Colorectal Neoplasm - Pipeline Insight, 2024 - Product Thumbnail Image

Colorectal Neoplasm - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Myelocytic Leukemia (CML) - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Myelocytic Leukemia (CML) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Carcinoid Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Carcinoid Tumor - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Lymphoblastic Leukemia (ALL) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Brain Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
chemotherapy-induced bone marrow toxicities - Pipeline Insight, 2024 - Product Thumbnail Image

chemotherapy-induced bone marrow toxicities - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Fatty Pancreas - Pipeline Insight, 2024 - Product Thumbnail Image

Fatty Pancreas - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Blastic Plasmacytoid Dendritic cell neoplasm - Pipeline Insight, 2024 - Product Thumbnail Image

Blastic Plasmacytoid Dendritic cell neoplasm - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
TRK Fusion Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

TRK Fusion Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more